A 50-patient study explores lithotripsy-assisted stenting for calcified left main coronary disease, reporting expansion and ...
A 297-person MASLD trial found liver fat reductions across three lifestyle support approaches, with no significant ...
Starting donanemab two years earlier increased projected societal value by 32% in a US model that excluded treatment costs.
Explore Phase III data showing fractionated stereotactic radiosurgery improves survival after brain metastasis resection.
Children with EDDs showed early growth impairment, with persistent deficits linked to SPINK5 variants, highlighting the need for monitoring.
The UK's MHRA backs ASA action against oral weight-loss medicine adverts, reinforcing advertising restrictions to protect ...
Iambic Therapeutics targets an $806m valuation in its US IPO, with an AI-powered cancer drug pipeline and partnerships with AbbVie and Takeda.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results